Gianna Melillo

Researchers identified gene expression signatures associated with risk of type 1 diabetes (T1D).

CDC updates mask guidelines for vaccinated and unvaccinated Americans.

Study results highlight the economic toll of migraine on employers in Japan.

The CDC's Advisory Committee on Immunization Practices voted to uphold the original language of the emergency use authorization for Johnson & Johnson's COVID-19 vaccination, and is possible the 1-dose vaccine could resume Saturday.

With unprecedented pauses in air pollution emissions in spring 2020 and ongoing virus mitigation behaviors around the world, the COVID-19 pandemic presents an opportunity to better understand the impact of poor air quality on human health.

Research presented at the American Academy of Neurology's annual meeting indicates some air pollutants may be associated with increased rates of migraine prevalence and severity.

An analysis of an ongoing study on children genetically at risk of type 1 diabetes examines the monitoring behaviors of parents.

Data from a single health system show women who present to the emergency department for headache tend to do so during the preovulatory interval of their menstrual cycle.

An online tool developed to facilitate efficient patient-provider decisions on disease modifying drugs for multiple sclerosis (MS) ran into several challenges and warrants further study.

Data from a recent cross-sectional study show severity of atopic dermatitis (AD) is associated with prevalence of learning disorders among children.

The CDC's Advisory Committee on Immunization Practices (ACIP) declined to change the current recommendation to pause administration of Johnson & Johnson's COVID-19 vaccine.

Results of a questionnaire-based study show higher body mass index (BMI) is associated with worse migraine symptoms and comorbidities.

Deficiencies in immunoglobulin levels frequently coexist with type 1 diabetes (T1D) in pediatric patients according to new study results.

Results from a questionnaire-based study indicated an association between a history of abuse and increased sensory hypersensitivity symptoms among migraineurs.

Veterans Affairs data show that among patients with heart failure admitted to skilled nursing facilities, those with delirium exhibited decreased rates of functional recovery.

A review published in Neuropsychiatric Disease and Treatment highlights the lack of research on migraine prevalence and symptoms among postmenopausal women.

Researchers analyzed the impacts of different nutritional education programs among patients with type 1 diabetes (T1D).

Results of a retrospective cohort study show that utilization of erenumab was associated with a decreased use of acute and preventive prescription migraine medications. Although adherence to erenumab was higher than other traditional oral prophylactic migraine therapies, adherence rates can be improved.

Researchers used deidentified real-world data to assess characteristics of patients who have received erenumab since its approval.

To mark the beginning of National Minority Health Month, The American Journal of Managed Care® (AJMC®) takes a look at racial inequities in the COVID-19 vaccine rollout and speaks with one expert who fears reality is worse than data indicate.

Women who received a type 1 diabetes (T1D) diagnosis prior to menstruation onset exhibited shorter reproductive periods compared with healthy controls.

Using a support vector machine model, researchers were able to distinguish between eyes with pathologic myopia and healthy myopia.

Nicola Hanania, MD, MS, discusses the future of research on triple therapy and chronic obstructive pulmonary disease (COPD).

A cross-sectional study explores the relationship between magnesium, calcium dietary intake, and migraine among men and women.

Researchers developed regression formulas that may be clinically beneficial for estimating visual prognosis after astigmatic correction and determining the surgical indication of astigmatic correction.

Survey responses of 320 US hospitals highlight the dire consequences of the COVID-19 pandemic on facilities and point to a future of ongoing financial and staffing challenges.

Twice weekly high doses of carfilzomib in combination with lenalidomide and dexamethasone was tolerable and effective among patients with newly diagnosed multiple myeloma.

Study findings presented at ENDO 2021, the Endocrine Society's annual meeting, show rates of hearing loss among 28 patients who took teprotumumab were higher than previously reported in phase 2 and 3 trials.

Randomized clinical trial results published in Cephalalgia show that trans-nasal high-flow dry gas therapy may play a role in reducing migraine-associated pain.